Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) Given Average Rating of “Moderate Buy” by Analysts

Shares of Adlai Nortye Ltd. Sponsored ADR (NASDAQ:ANL) have received a consensus rating of “Moderate Buy” from the six brokerages that are presently covering the company, MarketBeat.com reports. One analyst has rated the stock with a sell rating and five have assigned a buy rating to the company. The average 12-month price target among brokerages that have updated their coverage on the stock in the last year is $24.25.

ANL has been the subject of several recent analyst reports. Weiss Ratings restated a “sell (e+)” rating on shares of Adlai Nortye in a research note on Tuesday, July 14th. Oppenheimer started coverage on Adlai Nortye in a research report on Thursday, May 28th. They set an “outperform” rating and a $32.00 price target on the stock. JonesTrading assumed coverage on Adlai Nortye in a report on Thursday, May 14th. They set a “buy” rating and a $22.00 price objective for the company. Cantor Fitzgerald assumed coverage on Adlai Nortye in a research report on Monday, June 22nd. They issued an “overweight” rating for the company. Finally, HC Wainwright boosted their target price on Adlai Nortye from $16.00 to $20.00 and gave the stock a “buy” rating in a research note on Monday, April 20th.

Institutional Investors Weigh In On Adlai Nortye

Institutional investors have recently added to or reduced their stakes in the business. Affinity Asset Advisors LLC purchased a new stake in shares of Adlai Nortye during the first quarter worth about $1,140,000. ADAR1 Capital Management LLC purchased a new position in shares of Adlai Nortye in the 1st quarter valued at approximately $816,000. Renaissance Technologies LLC acquired a new stake in Adlai Nortye in the 1st quarter worth approximately $457,000. Finally, SmartHarvest Portfolios LLC boosted its stake in Adlai Nortye by 8.5% in the 1st quarter. SmartHarvest Portfolios LLC now owns 16,367 shares of the company’s stock worth $113,000 after purchasing an additional 1,279 shares in the last quarter. Institutional investors and hedge funds own 35.21% of the company’s stock.

Adlai Nortye Stock Down 0.4%

Shares of Adlai Nortye stock opened at $13.23 on Tuesday. The firm’s 50 day moving average price is $11.26 and its 200-day moving average price is $10.52. Adlai Nortye has a 52-week low of $0.88 and a 52-week high of $17.25.

About Adlai Nortye

Adlai Nortye Inc (NASDAQ: ANL) is a specialty chemical manufacturer headquartered in China’s Jiangsu Province. The company focuses on the research, development, production and sale of fine chemicals, with a primary emphasis on amino acids and their derivatives.

Adlai Nortye’s product portfolio includes betaine compounds, a range of high-purity L-amino acids such as L-methionine, L-threonine and glycine, as well as various chemical intermediates. These offerings serve multiple end markets, including animal feed and nutrition, personal care and cosmetic formulations, pharmaceutical ingredients and industrial chemical processes.

The company operates multiple production facilities alongside an in-house research and development center dedicated to process innovation and quality control.